Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udo Rudloff

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Expert Opinion on Emerging Drugs|October 17, 2022
Emerging kinase inhibitors for the treatment of pancreatic ductal adenocarcinomaUdo Rudloff
Clinical and Experimental Gastroenterology|December 26, 2018
Gastric adenocarcinoma and proximal polyposis of the stomach: diagnosis and clinical perspectivesUdo Rudloff
Archives of Gynecology and Obstetrics|January 16, 2007
Trauma in pregnancyUdo Rudloff
Radiology|November 24, 2005
The spoke wheel sign: bowelUdo Rudloff
Archives of Gynecology and Obstetrics|August 9, 2005
Jewish gynecologists in Germany in the first half of the twentieth centuryUdo Rudloff, Hans Ludwig
Cell Cycle (Georgetown, Tex.)|April 21, 2010
A growing family: adding mutated Erbb4 as a novel cancer targetUdo Rudloff, Yardena Samuels
Surgery Today|May 25, 2007
Volvulus of an appendiceal mucocele: report of a caseUdo Rudloff, Sandeep Malhotra
Pigment Cell & Melanoma Research|October 22, 2009
TYRO3-mediated regulation of MITF: a novel target in melanoma?Udo Rudloff, Yardena Samuels
Expert Opinion on Emerging Drugs|May 12, 2025
Emerging therapeutics targeting tumor-associated macrophages for the treatment of solid organ cancersDandan Li, Udo Rudloff
Clinical and Translational Medicine|February 23, 2018
Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalkDandan Li, Winifred Lo, Udo Rudloff
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Expert Opinion on Emerging Drugs|October 17, 2022
Emerging kinase inhibitors for the treatment of pancreatic ductal adenocarcinomaUdo Rudloff
Clinical and Experimental Gastroenterology|December 26, 2018
Gastric adenocarcinoma and proximal polyposis of the stomach: diagnosis and clinical perspectivesUdo Rudloff
Archives of Gynecology and Obstetrics|January 16, 2007
Trauma in pregnancyUdo Rudloff
Radiology|November 24, 2005
The spoke wheel sign: bowelUdo Rudloff
Archives of Gynecology and Obstetrics|August 9, 2005
Jewish gynecologists in Germany in the first half of the twentieth centuryUdo Rudloff, Hans Ludwig
Cell Cycle (Georgetown, Tex.)|April 21, 2010
A growing family: adding mutated Erbb4 as a novel cancer targetUdo Rudloff, Yardena Samuels
Surgery Today|May 25, 2007
Volvulus of an appendiceal mucocele: report of a caseUdo Rudloff, Sandeep Malhotra
Pigment Cell & Melanoma Research|October 22, 2009
TYRO3-mediated regulation of MITF: a novel target in melanoma?Udo Rudloff, Yardena Samuels
Expert Opinion on Emerging Drugs|May 12, 2025
Emerging therapeutics targeting tumor-associated macrophages for the treatment of solid organ cancersDandan Li, Udo Rudloff
Clinical and Translational Medicine|February 23, 2018
Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalkDandan Li, Winifred Lo, Udo Rudloff
Pageof 8